4,4'-Dichloro-3-(3-ethoxybenzyl)-3'-(4-ethoxybenzyl)-1,1'-biphenyl
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

2176485-21-34,4'-Dichloro-3-(3-ethoxybenzyl)-3'-(4-ethoxybenzyl)-1,1'-biphenyl

● In Stock

Catalogue No.:VE008721
CAS No.:2176485-21-3
Mol. Formula:C30H28Cl2O2
Mol. Weight:491.45 g/mol

Additional information on CAS 2176485-21-3

Parent drug

Dapagliflozin

IUPAC Name

4, 4′-Dichloro-3-(3-ethoxybenzyl)-3′-(4-ethoxybenzyl)-1, 1′-biphenyl

Synonyms

N/A

Description

4,4'-Dichloro-3-(3-ethoxybenzyl)-3'-(4-ethoxybenzyl)-1,1'-biphenyl CAS No: 2176485-21-3 is an impurity of Dapagliflozin which is utilized along with diet and exercise, and sometimes with other medications, to lower blood sugar levels in adults with type 2 diabetes. It belongs to a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors which lowers blood sugar by causing the kidneys to eliminate more glucose in the urine.

References

“Dapagliflozin: MedlinePlus Drug Information.” Medlineplus.gov, Feb. 2022, medlineplus.gov/druginfo/meds/a614015.html.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url